Stockreport

Cue Biopharma to Present at Bloomberg Biotech Innovations Conference

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF CAMBRIDGE, Mass., April 05, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc., (NASDAQ:CUE) an immunotherapy company developing a novel, proprietary class of biologics engi [Read more]